Legend Biotech to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Company Updates - Legend Biotech Corporation will present the latest company updates at the 43rd Annual J.P. Morgan Healthcare Conference on January 14, 2025, at 3:45 p.m. PT [1] - The presentation will be led by Ying Huang, Ph.D., the Chief Executive Officer of the company [1] Access Information - Investors and interested parties can access the live audio webcast through the Investor Relations section of Legend's website, with a replay available approximately 48 hours after the event [2] Company Overview - Legend Biotech is a global biotechnology company focused on treating and potentially curing life-threatening diseases, headquartered in Somerset, New Jersey [3] - The company is developing advanced cell therapies utilizing various technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gammadelta T cell, and natural killer (NK) cell-based immunotherapy [3] - Legend Biotech operates three R&D sites globally to discover innovative therapeutics for patients [3]